Review
doi: 10.1037/e496182006-023.
Use of drug discrimination in drug abuse research
Affiliations
- PMID: 1369679
- DOI: 10.1037/e496182006-023
Item in Clipboard
Review
Use of drug discrimination in drug abuse research
NIDA Res Monogr.
1991.
No abstract available
Similar articles
-
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.Pharmacol Biochem Behav. 1997 Aug;57(4):737-48. doi: 10.1016/s0091-3057(96)00334-6. Pharmacol Biochem Behav. 1997. PMID: 9259001
-
Serotonergic mechanisms of hallucinogenic drug effects.Monogr Neural Sci. 1987;13:55-81. doi: 10.1159/000414570. Monogr Neural Sci. 1987. PMID: 2891030 Review. No abstract available.
-
The use of drug discrimination procedures to characterize hallucinogenic drug actions.Psychopharmacol Bull. 1986;22(3):959-67. Psychopharmacol Bull. 1986. PMID: 3797596 No abstract available.
-
Discriminative profile of MDMA.Pharmacol Biochem Behav. 1986 Jun;24(6):1533-7. doi: 10.1016/0091-3057(86)90480-6. Pharmacol Biochem Behav. 1986. PMID: 2874566
-
[Neurotoxicity of the drug Ecstasy. Functional consequences of serotonergic hypoactivity].Ugeskr Laeger. 1998 Oct 12;160(42):6088-91. Ugeskr Laeger. 1998. PMID: 9800515 Review. Danish.
Cited by
-
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.Pharmacol Biochem Behav. 2024 Oct;243:173836. doi: 10.1016/j.pbb.2024.173836. Epub 2024 Jul 26. Pharmacol Biochem Behav. 2024. PMID: 39067531 Review.
-
Prediction and Prevention of Prescription Drug Abuse: Role of Preclinical Assessment of Substance Abuse Liability.Methods Rep RTI Press. 2013 Jul:1-14. doi: 10.3768/rtipress.2013.op.0014.1307. Methods Rep RTI Press. 2013. PMID: 24008590 Free PMC article.